Given its involvement in cancer, high levels of AURKA have been linked to clinical aggressiveness, poor outcomes, unfavourable prognoses, therapeutic resistance, and increased early recurrence in HCC patients.80, 84. The gene discussed is AURKA; the disease is cancer.